In autoimmune diseases such as MS and T1D, GM-CSF+ Th cells frequently co-express T-bet and RORγt, forming hybrid Th1/Th17-like subsets with potent pro-inflammatory capacity 20, 21, 27, 31-33. Here, CSF2 is linked to myeloid sarcoma.